欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3507/001
药品名称Ipratropium Bromide Newline Pharma 20 mcg/actuation, pressurized inhalation, solution
活性成分
    • ipratropium bromide bromide 20.0 µg
剂型Pressurised inhalation, solution
上市许可持有人Newline Pharma, S.L.
参考成员国 - 产品名称Netherlands (NL)
Ipratropiumbromide Newline Pharma 20 microgram/verstuiving aërosol,oplossing
互认成员国 - 产品名称
    • Germany (DE)
      Ipratropiumbromid Newline Pharma 20 Mikrogramm/Sprühstoß Druckgasinhalation, Lösung
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Estonia (EE)
      IPRATROPIUM BROMIDE NEWLINE PHARMA
许可日期2016/05/24
最近更新日期2024/04/04
药物ATC编码
    • R03BB01 ipratropium bromide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase